These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 34589873)

  • 1. Deletion of indoleamine 2,3 dioxygenase (Ido)1 but not Ido2 exacerbates disease symptoms of MOG
    Wetzel LA; Hurtado M; MacDowell Kaswan ZA; McCusker RH; Steelman AJ
    Brain Behav Immun Health; 2020 Aug; 7():100116. PubMed ID: 34589873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Smek1 deficiency exacerbates experimental autoimmune encephalomyelitis by activating proinflammatory microglia and suppressing the IDO1-AhR pathway.
    Duan RN; Yang CL; Du T; Liu A; Wang AR; Sun WJ; Li X; Li JX; Yan CZ; Liu QJ
    J Neuroinflammation; 2021 Jun; 18(1):145. PubMed ID: 34183017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of indoleamine 2,3-dioxygenase 1 expression in neurons of the central nervous system through inhibition of histone deacetylases blocks the progression of experimental autoimmune encephalomyelitis.
    Kim CE; Lee SM; Yoon EH; Won HJ; Jung YJ; Jegal Y; Kim DH; Kwon B; Seo SK
    Int Immunopharmacol; 2024 Jun; 134():112246. PubMed ID: 38759372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential Roles of IDO1 and IDO2 in T and B Cell Inflammatory Immune Responses.
    Merlo LMF; DuHadaway JB; Montgomery JD; Peng WD; Murray PJ; Prendergast GC; Caton AJ; Muller AJ; Mandik-Nayak L
    Front Immunol; 2020; 11():1861. PubMed ID: 32973768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of Indoleamine-2,3-Dioxygenase and Kynurenine Pathway in Experimental Autoimmune Encephalomyelitis in Mice.
    Zarzecki MS; Cattelan Souza L; Giacomeli R; Silva MRP; Prigol M; Boeira SP; Jesse CR
    Neurochem Res; 2020 Dec; 45(12):2959-2977. PubMed ID: 33040279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kynurenine pathway modulation reverses the experimental autoimmune encephalomyelitis mouse disease progression.
    Sundaram G; Lim CK; Brew BJ; Guillemin GJ
    J Neuroinflammation; 2020 Jun; 17(1):176. PubMed ID: 32505212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kynurenine produced by indoleamine 2,3-dioxygenase 2 exacerbates acute liver injury by carbon tetrachloride in mice.
    Hoshi M; Osawa Y; Nakamoto K; Morita N; Yamamoto Y; Ando T; Tashita C; Nabeshima T; Saito K
    Toxicology; 2020 May; 438():152458. PubMed ID: 32289347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IDO2 is critical for IDO1-mediated T-cell regulation and exerts a non-redundant function in inflammation.
    Metz R; Smith C; DuHadaway JB; Chandler P; Baban B; Merlo LM; Pigott E; Keough MP; Rust S; Mellor AL; Mandik-Nayak L; Muller AJ; Prendergast GC
    Int Immunol; 2014 Jul; 26(7):357-67. PubMed ID: 24402311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunomodulatory Factors Galectin-9 and Interferon-Gamma Synergize to Induce Expression of Rate-Limiting Enzymes of the
    Brooks AK; Lawson MA; Rytych JL; Yu KC; Janda TM; Steelman AJ; McCusker RH
    Front Immunol; 2016; 7():422. PubMed ID: 27799931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low efficiency IDO2 enzymes are conserved in lower vertebrates, whereas higher efficiency IDO1 enzymes are dispensable.
    Yuasa HJ; Mizuno K; Ball HJ
    FEBS J; 2015 Jul; 282(14):2735-45. PubMed ID: 25950090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on tissue and cellular distribution of indoleamine 2,3-dioxygenase 2: the absence of IDO1 upregulates IDO2 expression in the epididymis.
    Fukunaga M; Yamamoto Y; Kawasoe M; Arioka Y; Murakami Y; Hoshi M; Saito K
    J Histochem Cytochem; 2012 Nov; 60(11):854-60. PubMed ID: 22895526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GCN2 kinase plays an important role triggering the remission phase of experimental autoimmune encephalomyelitis (EAE) in mice.
    Orsini H; Araujo LP; Maricato JT; Guereschi MG; Mariano M; Castilho BA; Basso AS
    Brain Behav Immun; 2014 Mar; 37():177-86. PubMed ID: 24362236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of IDO1 and IDO2 on the B Cell Immune Response.
    Merlo LMF; Peng W; Mandik-Nayak L
    Front Immunol; 2022; 13():886225. PubMed ID: 35493480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IDO1 and IDO2 are expressed in human tumors: levo- but not dextro-1-methyl tryptophan inhibits tryptophan catabolism.
    Löb S; Königsrainer A; Zieker D; Brücher BL; Rammensee HG; Opelz G; Terness P
    Cancer Immunol Immunother; 2009 Jan; 58(1):153-7. PubMed ID: 18418598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IDO2 in Immunomodulation and Autoimmune Disease.
    Prendergast GC; Metz R; Muller AJ; Merlo LM; Mandik-Nayak L
    Front Immunol; 2014; 5():585. PubMed ID: 25477879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization and evolution of vertebrate indoleamine 2, 3-dioxygenases IDOs from monotremes and marsupials.
    Yuasa HJ; Ball HJ; Ho YF; Austin CJ; Whittington CM; Belov K; Maghzal GJ; Jermiin LS; Hunt NH
    Comp Biochem Physiol B Biochem Mol Biol; 2009 Jun; 153(2):137-144. PubMed ID: 19416693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-nucleotide polymorphisms and activities of indoleamine 2,3-dioxygenase isoforms, IDO1 and IDO2, in tuberculosis patients.
    Cao T; Dai G; Chu H; Kong C; Duan H; Tian N; Sun Z
    Hereditas; 2022 Jan; 159(1):5. PubMed ID: 35045867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IDO1 Deficiency Does Not Affect Disease in Mouse Models of Systemic Juvenile Idiopathic Arthritis and Secondary Hemophagocytic Lymphohistiocytosis.
    Put K; Brisse E; Avau A; Imbrechts M; Mitera T; Janssens R; Proost P; Fallarino F; Wouters CH; Matthys P
    PLoS One; 2016; 11(2):e0150075. PubMed ID: 26914138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ido2 Deficiency Exacerbates Motor Impairment and Reduces Aryl Hydrocarbon Receptor Activity through Decreased Kynurenine in a Chronic Demyelinating Mouse Model.
    Kunisawa K; Hara M; Yoshidomi K; Kon Y; Yamamoto Y; Fujigaki S; Wulaer B; Kosuge A; Tanabe M; Saitoh S; Takahashi K; Saito K; Nabeshima T; Mouri A
    Mol Neurobiol; 2024 Jun; ():. PubMed ID: 38829509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deletion of TDO2, IDO-1 and IDO-2 differentially affects mouse behavior and cognitive function.
    Too LK; Li KM; Suarna C; Maghzal GJ; Stocker R; McGregor IS; Hunt NH
    Behav Brain Res; 2016 Oct; 312():102-17. PubMed ID: 27316339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.